GE HealthCare Technologies Inc. (GEHC)

US — Healthcare Sector
Peers: HUM  IQV  CAH  INSM  ALC  ONC  RMD  A  MTD  PHG 

Automate Your Wheel Strategy on GEHC

With Tiblio's Option Bot, you can configure your own wheel strategy including GEHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol GEHC
  • Rev/Share 44.3969
  • Book/Share 22.4123
  • PB 3.7824
  • Debt/Equity 1.0752
  • CurrentRatio 1.1807
  • ROIC 0.0799

 

  • MktCap 37860192842.0
  • FreeCF/Share 3.0702
  • PFCF 27.043
  • PE 17.0568
  • Debt/Assets 0.2974
  • DivYield 0.0017
  • ROE 0.2374

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 2
  • DCF Score 4
  • P/B Score 2
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation GEHC Barclays -- Equal Weight -- $86 Oct. 13, 2025
Downgrade GEHC Citigroup Buy Neutral -- $83 Oct. 7, 2025
Upgrade GEHC UBS Sell Neutral -- $73 May 5, 2025
Upgrade GEHC Goldman Neutral Buy $85 $100 March 11, 2025
Upgrade GEHC Jefferies Hold Buy $95 $103 Jan. 8, 2025
Downgrade GEHC UBS Neutral Sell $84 $74 Sept. 26, 2024
Upgrade GEHC BTIG Research Neutral Buy -- $100 Sept. 18, 2024
Initiation GEHC JP Morgan -- Neutral -- $90 Sept. 9, 2024

News

Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
GEHC
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Read More
image for news Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
GEHC Expands Healthcare Access Through Indonesia MoH Partnership Deal
GEHC
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare partners with Indonesia's Health Ministry under SIHREN to deploy CT scanners nationwide, expanding diagnostics across public hospitals.

Read More
image for news GEHC Expands Healthcare Access Through Indonesia MoH Partnership Deal
3 MedTech Stocks Poised to Gain in 2026 From the AI Boom
GEHC, SYK, TEM
Published: December 16, 2025 by: Zacks Investment Research
Sentiment: Positive

AI is reshaping MedTech, and Stryker, Tempus AI and GE HealthCare are emerging as key players leveraging AI across surgery, diagnostics and imaging.

Read More
image for news 3 MedTech Stocks Poised to Gain in 2026 From the AI Boom
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
GEHC
Published: December 15, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
Earnings Growth & Price Strength Make GE HealthCare Technologies (GEHC) a Stock to Watch
GEHC
Published: December 08, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Read More
image for news Earnings Growth & Price Strength Make GE HealthCare Technologies (GEHC) a Stock to Watch
GEHC Forms 7-Year Care Alliance to Advance URMC Imaging & Monitoring
GEHC
Published: December 05, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare's seven-year alliance with URMC advances imaging, precision medicine and system-wide monitoring upgrades across UR Medicine.

Read More
image for news GEHC Forms 7-Year Care Alliance to Advance URMC Imaging & Monitoring
GEHC and Mayo Clinic Launch GEMINI-RT to Aid Personalized Cancer Care
GEHC
Published: December 04, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare and Mayo Clinic unveil GEMINI-RT, which is likely to blend imaging, AI and monitoring to advance personalized cancer care.

Read More
image for news GEHC and Mayo Clinic Launch GEMINI-RT to Aid Personalized Cancer Care
GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care
GEHC
Published: December 03, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) and Mayo Clinic today announced the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious new collaboration that aims to transform personalized radiation therapy and cancer care. Building on decades of collaboration and the original Strategic Radiology Research Collaboration signed in 2023, GEMINI-RT plans to drive innovation in prediction, planning, automation, workflow and monitoring for radiation onc.

Read More
image for news GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care
GEHC Unveils Allia Moveo to Elevate Mobility in Interventional Care
GEHC
Published: December 02, 2025 by: Zacks Investment Research
Sentiment: Neutral

GE HealthCare launches Allia Moveo with a cable-free C-arm and AI tools, aiming to elevate mobility, access and workflow in interventional care.

Read More
image for news GEHC Unveils Allia Moveo to Elevate Mobility in Interventional Care
GE HealthCare Unveils Next-Gen SIGNA MRI Systems to Elevate Efficiency
GEHC
Published: December 01, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's new SIGNA MRI lineup debuts AI-driven speed, sustainable design and advanced imaging aimed at boosting productivity.

Read More
image for news GE HealthCare Unveils Next-Gen SIGNA MRI Systems to Elevate Efficiency
GE HealthCare (GEHC) Up 7.5% Since Last Earnings Report: Can It Continue?
GEHC
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock?

Read More
image for news GE HealthCare (GEHC) Up 7.5% Since Last Earnings Report: Can It Continue?
Here's Why GE HealthCare Technologies (GEHC) is a Strong Momentum Stock
GEHC
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Here's Why GE HealthCare Technologies (GEHC) is a Strong Momentum Stock
GEHC Stock Gains Post Latest Launch to Optimize Radiology Workflows
GEHC
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare unveils Genesis Radiology Workspace, aiming to streamline imaging workflows and boost diagnostic precision.

Read More
image for news GEHC Stock Gains Post Latest Launch to Optimize Radiology Workflows
Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
GEHC
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Read More
image for news Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging
GEHC
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's $2.3B Intelerad deal aims to accelerate cloud imaging growth, expand outpatient reach and boost its shift toward high-margin SaaS revenue.

Read More
image for news GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging
GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies London Healthcare Conference 2025 Transcript
GEHC
Published: November 18, 2025 by: Seeking Alpha
Sentiment: Neutral

GE HealthCare Technologies Inc. ( GEHC ) Jefferies London Healthcare Conference 2025 November 18, 2025 4:30 AM EST Company Participants James Saccaro - VP & CFO Carolynne Borders - Chief Investor Relations Officer Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division Thanks for joining us here at the Jefferies Global Healthcare Conference, the JPMorgan of the East. So I'm Matt Taylor, the U.S. Medical supplies and devices analyst here at Jefferies, and I'm joined by the management team from GE Healthcare.

Read More
image for news GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies London Healthcare Conference 2025 Transcript
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
GEHC
Published: November 13, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
Why GE HealthCare Technologies (GEHC) is a Top Momentum Stock for the Long-Term
GEHC
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Why GE HealthCare Technologies (GEHC) is a Top Momentum Stock for the Long-Term
GEHC vs. ESLOY: Which Stock Is the Better Value Option?
ESLOY, GEHC
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best option for those looking for undervalued stocks?

Read More
image for news GEHC vs. ESLOY: Which Stock Is the Better Value Option?
GE HealthCare Technologies Inc. (GEHC) Q3 2025 Earnings Call Transcript
GEHC
Published: October 29, 2025 by: Seeking Alpha
Sentiment: Neutral

GE HealthCare Technologies Inc. ( GEHC ) Q3 2025 Earnings Call October 29, 2025 8:30 AM EDT Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President, CEO & Director James Saccaro - VP & CFO Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Travis Steed - BofA Securities, Research Division Joanne Wuensch - Citigroup Inc., Research Division David Roman - Goldman Sachs Group, Inc., Research Division Patrick Wood - Morgan Stanley, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Robert Marcus …

Read More
image for news GE HealthCare Technologies Inc. (GEHC) Q3 2025 Earnings Call Transcript
GE HealthCare Technologies (GEHC) Surpasses Q3 Earnings and Revenue Estimates
GEHC
Published: October 29, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.14 per share a year ago.

Read More
image for news GE HealthCare Technologies (GEHC) Surpasses Q3 Earnings and Revenue Estimates
GE HealthCare boosts 2025 profit view after strong US demand helps third quarter
GEHC
Published: October 29, 2025 by: Reuters
Sentiment: Positive

GE HealthCare Technologies raised its annual adjusted profit forecast and beat estimates for third-quarter results on Wednesday, powered by strong demand for its medical devices in the United States and the Europe, Middle East, and Africa region.

Read More
image for news GE HealthCare boosts 2025 profit view after strong US demand helps third quarter
GE HealthCare Tech Profit Slides as Tariffs Drag
GEHC
Published: October 29, 2025 by: WSJ
Sentiment: Negative

GE HealthCare Technologies' said profit fell in the third quarter, weighed down by the added costs of tariffs.

Read More
image for news GE HealthCare Tech Profit Slides as Tariffs Drag
GE HealthCare reports third quarter 2025 financial results
GEHC
Published: October 29, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment environment. Revenue performance was driven by Imaging, Advanced Visualization Solutions, and Pharmaceutical Diagnostics, and was ah.

Read More
image for news GE HealthCare reports third quarter 2025 financial results
Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?
GEHC
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Neutral

GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.

Read More
image for news Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
GEHC
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.

Read More
image for news GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
GEHC
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.

Read More
image for news GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
GEHC
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.

Read More
image for news GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GEHC
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.

Read More
image for news GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GEHC or A: Which Is the Better Value Stock Right Now?
A, GEHC
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?

Read More
image for news GEHC or A: Which Is the Better Value Stock Right Now?

About GE HealthCare Technologies Inc. (GEHC)

  • IPO Date 2022-12-15
  • Website https://www.gehealthcare.com
  • Industry Medical - Healthcare Information Services
  • CEO Peter J. Arduini
  • Employees 53000

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.